Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F09%3A00209017" target="_blank" >RIV/00216208:11150/09:00209017 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

Original language description

To assess the effect of denosumab (dose 60 mg s.c. once in 6 months for three years) on the fracture ris in postmenopausal women (n=7868) in a double blind, pacebo controlled, randomized clinical trial. Denosumab decreased the risk of new fractures at the spine (by 68%), hip fractures (by 40%), non-vertebral fractures (by 20%). The safety profile of denosumab was very good, comparable to placebo.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FG - Paediatrics

OECD FORD branch

—

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2009

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

New England Journal of Medicine

ISSN

0028-4793

e-ISSN

—

Volume of the periodical

361

Issue of the periodical within the volume

8

Country of publishing house

US - UNITED STATES

Number of pages

10

Pages from-to

—

UT code for WoS article

000269081200004

EID of the result in the Scopus database

—